Article and Video CATEGORIES

Cancer Journey

Search By

OncTalk 2021 - Is Broad Next Generation Sequencing (NGS) the Standard of Care?
OncTalk 2021 - Is Broad Next Generation Sequencing (NGS) the Standard of Care?
Author
GRACE Videos and Articles
Image
onctalk 2021

OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This event was chaired by Ibiayi Dagog-Jack, MD, with co-chair H. Jack West, MD.

For the full agenda, https://cancergrace.org/onctalk-2021-agenda, and for information on the faculty, https://cancergrace.org/onctalk-2021-faculty-bios.

In this video, from the second-panel discussion on Advanced NSCLC with Ibiayi Dagogo-Jack, MD, and Drs. Melina Marmarelis, Adrian Sacher, and Aparna Hegde, the panel discuss if broad next-generation sequencing (NGS) is the standard of care.

A huge thank you to our sponsor! #takedaoncology

takeda Oncology

To join the conversation, visit https://cancergrace.org/forum.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Clinical Trials Storytelling 2025
Article
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program
Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!